CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

251 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-01

Study Completion Date

2018-09-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The state of health in France appears to be good with regard to major indicators such as life expectancy at birth.

However, France is characterized by a high standardized rate of premature mortality (deaths occurring before the age of 65) in comparison with other European countries, with geographical disparities. Between 2006 and 2010, the standardized rate of premature mortality was higher in Auvergne than the national average.

Chronic diseases such as cardiovascular diseases, cancers and / or metabolic diseases (including diabetes and obesity) are the main causes of these premature deaths. These diseases have several causes: they depend on the genetic heritage, the way of life and the environment. Family history is a known risk factor for these chronic diseases. Eating habits, insufficient physical activity or physical inactivity, excessive drinking and smoking which promote the occurrence of these chronic diseases are the main risk factors that we can modify. Preventive measures are known and are regularly the subject of public health plans and awareness campaigns targeting lifestyles modification of the populations. These prevention campaigns affect entire population, while the risk factors for chronic diseases are different from one to another, this encourages personalization of preventive measures. The CEPPPIA pilot study falls within this framework and aims to evaluate the feasibility of setting up an individualized prevention program on the modification of health behaviors among people aged 35 to 55, who has a moderate risk of developing chronic diseases and residing in Auvergne territory.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Food Typologies and Multidimensional Phenotyping of Elderly in Auvergne-Rhône-Alpes (Part'AGE)

NCT06695780

Nutritional Assessment Physical Activity Health +1 more

RECRUITING

Elders Preserving Independence in the Community

NCT05381480

Healthy Aging

TERMINATED NA

Personalised Primary Prevention Intervention for Vulnerable Informal Caregivers at Increased Risk of Cancer

NCT05310045

Informal Caregivers Healthy Volunteers Family +1 more

COMPLETED

"Cook to Health Study 2 ": Monitoring Wellbeing and Health in the Community (Main Study)

NCT03169088

Healthy

COMPLETED NA

Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young Adults

NCT03964116

Cancer Adolescent Behavior Young Adult

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The state of health in France appears to be good with regard to major indicators such as life expectancy at birth.

However, France is characterized by a high standardized rate of premature mortality (deaths occurring before the age of 65) in comparison with other European countries, with geographical disparities. Between 2006 and 2010, the standardized rate of premature mortality was higher in Auvergne than the national average.

Chronic diseases such as cardiovascular diseases, cancers and / or metabolic diseases (including diabetes and obesity) are the main causes of these premature deaths. These diseases have several causes: they depend on the genetic heritage, the way of life and the environment. Family history is a known risk factor for these chronic diseases. Eating habits, insufficient physical activity or physical inactivity, excessive drinking and smoking which promote the occurrence of these chronic diseases are the main risk factors that we can modify. Preventive measures are known and are regularly the subject of public health plans and awareness campaigns targeting lifestyles modification of the populations. These prevention campaigns affect entire population, while the risk factors for chronic diseases are different from one to another, this encourages personalization of preventive measures. The CEPPPIA pilot study falls within this framework and aims to evaluate the feasibility of setting up an individualized prevention program on the modification of health behaviors among people aged 35 to 55, who has a moderate risk of developing chronic diseases and residing in Auvergne territory.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Disease Cardiovascular Diseases Cancers Diabetes Mellitus Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

No masking

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

adults aged 35 to 55 years

Group Type EXPERIMENTAL

online questionnaire

Intervention Type BEHAVIORAL

Risk assessment identified by online questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

online questionnaire

Risk assessment identified by online questionnaire

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women aged 35 to 55 years
* Subjects identified as moderate risk (group G1) following the assessment of the level of risk
* Covered by the Social Security
* Having signed the information form and having given his / her free consent during the inclusion visit
* Judged able to understand the aims of the study and ready to accept the constraints

Exclusion Criteria

* Age \<35 years or\> 55 years
* Person who has not completed and validated the FSI (online health questionnaire)
* Person belonging to group G1 but with a moderate pathological risk (P1) and no identifiable risk in the behavioral field (C0)
* Pregnant or lactating women
* Persons benefiting from a legal protection measure
* Persons refusing to sign information and consent form
* Person in an exclusion period from another study, or having received more than 4500 € in the year
* Person deprived of his liberty by judicial or administrative decision
* Medical or surgical history, judged by the investigator to be incompatible with the study
* Suspicion of psychiatric disorders judged by the investigator to be incompatible with the study

Minimum Eligible Age

35 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes